文献速递淋巴瘤白血病

大型法国多中心队列中淋巴瘤相关噬血细胞综合征的综合分析发现改善预后的线索

A comprehensive analysis of Lymphoma-associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis.
PubMed 文献 · Br J Haematol · 2018-07-24

该研究报道法国多中心队列中71例淋巴瘤相关噬血细胞综合征(LAHS)患者,淋巴瘤以侵袭性为主,30天早期死亡率为26.8%,6个月总生存率45.7%,2年总生存率34.3%。并发感染、年龄超过50岁、种族和依托泊苷治疗与死亡独立相关。

要点

  • 法国多中心队列71例LAHS患者中,30天早期死亡率为26.8%。
  • 总生存率6个月为45.7%,2年为34.3%。
  • 并发感染、年龄超过50岁、种族和依托泊苷治疗与死亡独立相关。

核心结论

  • LAHS总体预后差,早期死亡率尤其高,强调早期识别和选择初始治疗的重要性。

研究设计与样本

  • 法国多中心队列病例系列,纳入71例淋巴瘤相关噬血细胞综合征患者。

主要发现

  • 淋巴瘤类型包括非霍奇金B细胞淋巴瘤46.5%(含人疱疹病毒8相关非霍奇金淋巴瘤12.7%)、T细胞淋巴瘤28.2%和霍奇金淋巴瘤23.9%。
  • 30例患者(42.3%)存在基础免疫缺陷。
  • 噬血细胞综合征诊断后30天内早期死亡率为26.8%。
  • 总生存率6个月为45.7%[95%置信区间(CI)35.4-59.0],2年为34.3%[95%CI 24.8-47.4]。
  • 并发感染、年龄超过50岁、种族和依托泊苷治疗与死亡独立相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lymphoma-associated haemophagocytic syndrome (LAHS) accounts for most cases of secondary haemophagocytic syndrome (HS) and has been extensively described in Asian populations. However, little is known about the epidemiology of LAHS in Western countries. We herein report a case series of 71 LAHS patients in which the lymphomas were mainly of the aggressive type. Diagnoses included non-Hodgkin B cell lymphoma (46·5%) including human herpes virus 8-associated non-Hodgkin lymphoma (12·7%), T cell lymphoma (28·2%) and Hodgkin lymphoma (23·9%). An underlying immunodeficiency was described in 30 patients (42·3%). Early mortality within the 30 days following HS diagnosis was observed in 26·8% of cases. The overall survival was estimated at 45·7% [95% confidence interval, CI (35·4-59·0)] at 6 months, and 34·3% [95% CI (24·8-47·4)] at 2 years. Concurrent infection, age over 50 years, ethnicity and etoposide treatment were independently associated with mortality. While it appears that certain types of lymphomas were more prone to trigger HS, LAHS were not restricted to a few types of lymphoma. The overall prognosis was poor, with a particularly high rate of early mortality, highlighting the importance of both early recognition and choice of initial therapeutic management.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Bigenwald C, Fardet L, Coppo P, et al. A comprehensive analysis of Lymphoma-associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis. Br J Haematol. 2018. PMID: 30043391. doi:10.1111/bjh.15506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。